Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kontafarma China
Wan Chai, Hong Kong
- Ownership
- Private
- Employees
- ~714
- Development stage
- Other
01
Overview
Kontafarma China manufactures and sells prescription chemical drugs and traditional Chinese medicines (TCMs), and also operates fitness and wellness centers. It focuses on the Chinese market, with international presence in Singapore and Taiwan. The company maintains a strong commercial presence in drug manufacturing with ongoing R&D but no disclosed late-stage clinical assets.
- Modalities
- Small moleculeTraditional Chinese medicine
- Industry
- Biotech
Beyond the preview
Go deeper on Kontafarma China.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kontafarma China.